Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study

Fig. 1

Boxplot of numeric rating scale (NRS 0–10) scores for pain and pruritus prior to- and after cannabinoid-based medication (CBM) administration. Note the improvement in the perception of both pain and pruritus following CBM use. Significant differences (p < 0.001) were seen for changes in pain and pruritus (prior to CBM-use vs. after CBM-use)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172